Silveira-Moriyama L - Search Results

1

Silveira-Moriyama L, Birchall J, Bain P, Lees AJ, Bajaj NP. Silveira-Moriyama L, et al. Mov Disord. 2015 Sep;30(10):1436-7. doi: 10.1002/mds.26344. Epub 2015 Jul 31. Mov Disord. 2015. PMID: 26227990 No abstract available.

2

Chediak-Higashi syndrome with parkinsonism.

Silveira-Moriyama L, Moriyama TS, Gabbi TV, Ranvaud R, Barbosa ER. Silveira-Moriyama L, et al. Mov Disord. 2004 Apr;19(4):472-5. doi: 10.1002/mds.10677. Mov Disord. 2004. PMID: 15077248

3

Punding and dyskinesias.

Silveira-Moriyama L, Evans AH, Katzenschlager R, Lees AJ. Silveira-Moriyama L, et al. Mov Disord. 2006 Dec;21(12):2214-7. doi: 10.1002/mds.21118. Mov Disord. 2006. PMID: 17013916

4

Nonmotor symptoms as presenting complaints in Parkinson's disease: a clinicopathological study.

O'Sullivan SS, Williams DR, Gallagher DA, Massey LA, Silveira-Moriyama L, Lees AJ. O'Sullivan SS, et al. Mov Disord. 2008 Jan;23(1):101-6. doi: 10.1002/mds.21813. Mov Disord. 2008. PMID: 17994582

5

Clinical outcomes of progressive supranuclear palsy and multiple system atrophy.

O'Sullivan SS, Massey LA, Williams DR, Silveira-Moriyama L, Kempster PA, Holton JL, Revesz T, Lees AJ. O'Sullivan SS, et al. Brain. 2008 May;131(Pt 5):1362-72. doi: 10.1093/brain/awn065. Epub 2008 Apr 2. Brain. 2008. PMID: 18385183

6

The use of smell identification tests in the diagnosis of Parkinson's disease in Brazil.

Silveira-Moriyama L, Carvalho Mde J, Katzenschlager R, Petrie A, Ranvaud R, Barbosa ER, Lees AJ. Silveira-Moriyama L, et al. Mov Disord. 2008 Dec 15;23(16):2328-34. doi: 10.1002/mds.22241. Mov Disord. 2008. PMID: 18785265

7

Hyposmia in G2019S LRRK2-related parkinsonism: clinical and pathologic data.

Silveira-Moriyama L, Guedes LC, Kingsbury A, Ayling H, Shaw K, Barbosa ER, Bonifati V, Quinn NP, Abou-Sleiman P, Wood NW, Petrie A, Sampaio C, Ferreira JJ, Holton J, Revesz T, Lees AJ. Silveira-Moriyama L, et al. Neurology. 2008 Sep 23;71(13):1021-6. doi: 10.1212/01.wnl.0000326575.20829.45. Neurology. 2008. PMID: 18809839

8

Can olfactory bulb biopsy be justified for the diagnosis of Parkinson's disease? Comments on "olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders".

Parkkinen L, Silveira-Moriyama L, Holton JL, Lees AJ, Revesz T. Parkkinen L, et al. Acta Neuropathol. 2009 Feb;117(2):213-4; author reply 217-8. doi: 10.1007/s00401-008-0462-3. Epub 2008 Nov 25. Acta Neuropathol. 2009. PMID: 19031077 No abstract available.

9

Evidence for pre and postsynaptic nigrostriatal dysfunction in the fragile X tremor-ataxia syndrome.

Healy DG, Bressman S, Dickson J, Silveira-Moriyama L, Schneider SA, Sullivan SS, Massey L, Bhatia KP, Shaw K, Bhatia KP, Bomanji J, Wood NW, Lees AJ. Healy DG, et al. Mov Disord. 2009 Jun 15;24(8):1245-7. doi: 10.1002/mds.22267. Mov Disord. 2009. PMID: 19260103 No abstract available.

10

Olfaction in patients with suspected parkinsonism and scans without evidence of dopaminergic deficit (SWEDDs).

Silveira-Moriyama L, Schwingenschuh P, O'Donnell A, Schneider SA, Mir P, Carrillo F, Terranova C, Petrie A, Grosset DG, Quinn NP, Bhatia KP, Lees AJ. Silveira-Moriyama L, et al. J Neurol Neurosurg Psychiatry. 2009 Jul;80(7):744-8. doi: 10.1136/jnnp.2009.172825. Epub 2009 Mar 9. J Neurol Neurosurg Psychiatry. 2009. PMID: 19276101 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

85 results

Search Page